YIH
ITCI
Y-Intercept (HK)’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,525
| Closed | -$545K | – | 1688 |
|
|
2024
Q4 | $545K | Sell |
6,525
-7,126
| -52% | -$595K | 0.04% | 686 |
|
|
2024
Q3 | $999K | Sell |
13,651
-62,349
| -82% | -$4.56M | 0.06% | 449 |
|
|
2024
Q2 | $5.21M | Buy |
76,000
+59,696
| +366% | +$4.09M | 0.29% | 62 |
|
|
2024
Q1 | $1.13M | Buy |
+16,304
| New | +$1.13M | 0.09% | 338 |
|
|
2023
Q2 | – | Sell |
-25,982
| Closed | -$1.41M | – | 1805 |
|
|
2023
Q1 | $1.41M | Buy |
25,982
+6,739
| +35% | +$365K | 0.16% | 168 |
|
|
2022
Q4 | $1.02M | Buy |
+19,243
| New | +$1.02M | 0.15% | 195 |
|
|
2022
Q3 | – | Sell |
-3,593
| Closed | -$205K | – | 1334 |
|
|
2022
Q2 | $205K | Sell |
3,593
-756
| -17% | -$43.1K | 0.03% | 678 |
|
|
2022
Q1 | $266K | Sell |
4,349
-923
| -18% | -$56.5K | 0.06% | 499 |
|
|
2021
Q4 | $276K | Buy |
+5,272
| New | +$276K | 0.07% | 422 |
|
|
2021
Q1 | – | Sell |
-10,453
| Closed | -$337K | – | 851 |
|
|
2020
Q4 | $337K | Buy |
+10,453
| New | +$337K | 0.14% | 272 |
|